Intelligent Bio Solutions INBS
NASDAQ INBS
$1.72 +0.05 (+3.09%)
As of: Oct 1, 2026 · 12:16 PM EDT

Intelligent Bio Solutions (INBS) Other Non-Current Liabilities (2023)

Updated

Intelligent Bio Solutions (INBS) posted Other Non-Current Liabilities of $8,714 for fiscal Q4 2023 (quarter ended Jun 30, 2023).

Analysis

Intelligent Bio Solutions (INBS) Other Non-Current Liabilities (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Intelligent Bio Solutions 2.46 Mn -11.02 Mn 536,583.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 8,714.00
API Access

Intelligent Bio Solutions Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INBS&period=max&api_key=YOUR_API_KEY